Tables

Electronic Supplementary Material Table S1. Search strategy and results from each included database

Keywords / AMED / CINAHL / EMBASE / MEDLINE / WoS
ARTHRALGIA/ OR pain / 25135 / 216230 / 710407 / 441977 / 334687
KNEE JOINT/ OR KNEE/ OR PATELLA/ / 4166 / 9449 / 42923 / 49222 / 93798
1 AND 2 / 929 / 6526 / 7409 / 7494 / 16216
((((patell* OR femoropatell* OR femoro-patell* OR retropatell*) AND (pain OR syndrome OR dysfunction)))).ti,ab / 549 / 1199 / 4801 / 3904 / 1004
((((lateral compression OR lateral facet OR lateral pressure OR odd facet) AND (pain OR syndrome OR dysfunction)))).ti,ab / 3 / 344 / 27 / 20 / 28
((((chondromalac* OR chondropath*) AND (knee* OR patell* OR femoropatell* OR femoro-patell* OR retropatell*)))).ti,ab / 32 / 70 / 997 / 822 / 309
((anterior AND knee AND pain)).ti,ab / 241 / 535 / 2500 / 2038 / 296
3 OR 4 OR 5 OR 6 / 1201 / 7819 / 12322 / 10647 / 16952
predict*.ti,ab / 9532 / 93290 / 1029853 / 846964 / 384763
8 AND 9 / 63 / 387 / 631 / 484 / 323
ti = Title, ab = abstract

1

Electronic Supplementary Material Table S2 - Quality assessment score allocations for each included study, including subsequent inter-rater reliability for each item, component and overall score

Study / 1.1
IC
(/2) / 1.2
EC
(/2) / 1.3 Ad.no (/4) / 1.4 Hom (/2) / 1
Pop (/10) / 2.1
S/D (/4) / 2.2 C/PIA (/4) / 2.3
C/A (/2) / 2
Int
(/10) / 3.1
RO
(/4) / 3.2 BOA (/4) / 3.3 F/uA (/2) / 3
OM
(/10) / 4.1 RD (/2) / 4.2 Dropouts (/2) / 4.3 ITT (/2) / 4.4
SP
(/4) / 4
DP/A (/10) / Total score (/40) / TPS (%)
Witvrouw et al. [27] / 2 / 1 / 2 / 0 / 5 / 4 / 0 / 2 / 6 / 4 / 2 / 1 / 7 / 0 / 2 / 0 / 4 / 6 / 24 / 60
Barton et al. [20] / 2 / 2 / 2 / 0 / 6 / 4 / 0 / 2 / 6 / 4 / 0 / 1 / 5 / 0 / 1 / 0 / 4 / 5 / 22 / 55
Barton et al. [32] / 2 / 2 / 0 / 0 / 4 / 4 / 0 / 2 / 6 / 4 / 0 / 1 / 5 / 0 / 2 / 0 / 4 / 6 / 21 / 53
Crowell et al. [42] / 1 / 2 / 1 / 0 / 4 / 4 / 0 / 2 / 6 / 4 / 0 / 0 / 4 / 0 / 2 / 0 / 4 / 6 / 20 / 50
Iverson et al. [37] / 2 / 2 / 0 / 0 / 4 / 4 / 0 / 2 / 6 / 4 / 0 / 0 / 4 / 0 / 2 / 0 / 4 / 6 / 20 / 50
Pattyn et al. [25] / 2 / 1 / 1 / 0 / 4 / 4 / 0 / 1 / 5 / 3 / 2 / 0 / 5 / 0 / 2 / 0 / 4 / 6 / 20 / 50
Sutlive et al. [23] / 2 / 2 / 0 / 0 / 4 / 4 / 0 / 2 / 6 / 3 / 0 / 0 / 3 / 0 / 2 / 0 / 4 / 6 / 19 / 48
Lesher et al. [22] / 2 / 2 / 0 / 0 / 4 / 4 / 0 / 2 / 6 / 3 / 0 / 0 / 3 / 0 / 2 / 0 / 4 / 6 / 19 / 48
Lan et al. [30] / 2 / 2 / 2 / 0 / 6 / 4 / 0 / 0 / 4 / 4 / 0 / 0 / 4 / 0 / 2 / 0 / 2 / 4 / 18 / 45
Vicenzino et al. [19] / 2 / 2 / 0 / 0 / 4 / 4 / 0 / 0 / 4 / 4 / 0 / 1 / 5 / 0 / 1 / 0 / 4 / 5 / 18 / 45
Natri et al. [26] / 2 / 1 / 0 / 0 / 3 / 2 / 0 / 1 / 3 / 4 / 0 / 2 / 6 / 0 / 2 / 0 / 4 / 6 / 18 / 45
Kannus et el [31] / 2 / 1 / 0 / 0 / 3 / 2 / 0 / 1 / 3 / 4 / 0 / 2 / 6 / 0 / 2 / 0 / 4 / 6 / 18 / 45
Selfe et al. [29] / 1 / 2 / 2 / 0 / 5 / 2 / 0 / 2 / 4 / 4 / 0 / 1 / 5 / 0 / 1 / 0 / 1 / 2 / 16 / 40
Piva et al. [24] / 2 / 2 / 0 / 0 / 4 / 4 / 0 / 0 / 4 / 3 / 0 / 0 / 3 / 0 / 2 / 0 / 3 / 5 / 16 / 40
Wittstein et al. [28] / 1 / 1 / 2 / 0 / 4 / 2 / 0 / 0 / 2 / 3 / 0 / 0 / 3 / 0 / 2 / 0 / 4 / 6 / 15 / 38
IC=inclusion criteria; EC=exclusion criteria; Ad. no.=adequate number; Hom=homogeneity; Pop=population; S/D=standardized and described; C/PlA=control and placebo adequate; C/A=co-intervention avoided; Int=interventions; RO=relevant outcome; BOA=blinded outcome assessment; F/uA=follow-up adequate; OM=outcome measures; RD=randomization described; ITT=intention to treat; SP=statistical procedures; DP/A=data presentation and analysis;TPS = total possible score;

1